Global Oligonucleotide Bioconjugation Service Market Growth (Status and Outlook) 2026-2032

March 2026 | 123 pages | ID: G0E56F17E11EEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Oligonucleotide Bioconjugation Service market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

Oligonucleotide bioconjugation service refers to the conjugation of oligonucleotides with other biomolecules such as peptides, antibodies, etc. This conjugation can be used in a variety of research and applications, including: drug delivery, vaccine development, and gene therapy.

United States market for Oligonucleotide Bioconjugation Service is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Oligonucleotide Bioconjugation Service is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Oligonucleotide Bioconjugation Service is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Oligonucleotide Bioconjugation Service players cover WuXi TIDES, Bio-Synthesis Inc, Creative Biolabs, Creative Biogene (IntegrateRNA), CPC Scientific Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LPI (LP Information)' newest research report, the “Oligonucleotide Bioconjugation Service Industry Forecast” looks at past sales and reviews total world Oligonucleotide Bioconjugation Service sales in 2025, providing a comprehensive analysis by region and market sector of projected Oligonucleotide Bioconjugation Service sales for 2026 through 2032. With Oligonucleotide Bioconjugation Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oligonucleotide Bioconjugation Service industry.

This Insight Report provides a comprehensive analysis of the global Oligonucleotide Bioconjugation Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Oligonucleotide Bioconjugation Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oligonucleotide Bioconjugation Service market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oligonucleotide Bioconjugation Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oligonucleotide Bioconjugation Service.

This report presents a comprehensive overview, market shares, and growth opportunities of Oligonucleotide Bioconjugation Service market by product type, application, key players and key regions and countries.

Segmentation by Type:
  • Oligonucleotide-Peptide
  • Oligonucleotide-Antibody
  • Oligonucleotide-Lipid
  • Oligonucleotide-Toxin
  • Oligonucleotide-GalNAc
  • Other
Segmentation by Application:
  • Scientific Research
  • Pharmaceuticals
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • WuXi TIDES
  • Bio-Synthesis Inc
  • Creative Biolabs
  • Creative Biogene (IntegrateRNA)
  • CPC Scientific Inc.
  • BOCSCI Inc.
  • LifeTein
  • Ajinomoto
  • SBS Genetech
  • Medtide Inc.
  • Kaneka Corporation(Eurogentec)
  • Rockland
  • CellMosaic
  • Leinco
  • Lonza
  • ChemExpress
  • GTP Bioways
  • Biosynth


The report requires updating with new data and is sent in 48 hours after order is placed.
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Oligonucleotide Bioconjugation Service Market Size (2021-2032)
  2.1.2 Oligonucleotide Bioconjugation Service Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Oligonucleotide Bioconjugation Service by Country/Region (2021, 2025 & 2032)
2.2 Oligonucleotide Bioconjugation Service Segment by Type
  2.2.1 Oligonucleotide-Peptide
  2.2.2 Oligonucleotide-Antibody
  2.2.3 Oligonucleotide-Lipid
  2.2.4 Oligonucleotide-Toxin
  2.2.5 Oligonucleotide-GalNAc
  2.2.6 Other
  2.2.7 Oligonucleotide Bioconjugation Service Market Size by Type
    2.2.7.1 Oligonucleotide Bioconjugation Service Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.7.2 Global Oligonucleotide Bioconjugation Service Market Size Market Share by Type (2021-2026)
2.3 Oligonucleotide Bioconjugation Service Segment by Application
  2.3.1 Scientific Research
  2.3.2 Pharmaceuticals
  2.3.3 Oligonucleotide Bioconjugation Service Market Size by Application
    2.3.3.1 Oligonucleotide Bioconjugation Service Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.3.3.2 Global Oligonucleotide Bioconjugation Service Market Size Market Share by Application (2021-2026)

3 OLIGONUCLEOTIDE BIOCONJUGATION SERVICE MARKET SIZE BY PLAYER

3.1 Oligonucleotide Bioconjugation Service Market Size Market Share by Player
  3.1.1 Global Oligonucleotide Bioconjugation Service Revenue by Player (2021-2026)
  3.1.2 Global Oligonucleotide Bioconjugation Service Revenue Market Share by Player (2021-2026)
3.2 Global Oligonucleotide Bioconjugation Service Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 OLIGONUCLEOTIDE BIOCONJUGATION SERVICE BY REGION

4.1 Oligonucleotide Bioconjugation Service Market Size by Region (2021-2026)
4.2 Global Oligonucleotide Bioconjugation Service Annual Revenue by Country/Region (2021-2026)
4.3 Americas Oligonucleotide Bioconjugation Service Market Size Growth (2021-2026)
4.4 APAC Oligonucleotide Bioconjugation Service Market Size Growth (2021-2026)
4.5 Europe Oligonucleotide Bioconjugation Service Market Size Growth (2021-2026)
4.6 Middle East & Africa Oligonucleotide Bioconjugation Service Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Oligonucleotide Bioconjugation Service Market Size by Country (2021-2026)
5.2 Americas Oligonucleotide Bioconjugation Service Market Size by Type (2021-2026)
5.3 Americas Oligonucleotide Bioconjugation Service Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Oligonucleotide Bioconjugation Service Market Size by Region (2021-2026)
6.2 APAC Oligonucleotide Bioconjugation Service Market Size by Type (2021-2026)
6.3 APAC Oligonucleotide Bioconjugation Service Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Oligonucleotide Bioconjugation Service Market Size by Country (2021-2026)
7.2 Europe Oligonucleotide Bioconjugation Service Market Size by Type (2021-2026)
7.3 Europe Oligonucleotide Bioconjugation Service Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Oligonucleotide Bioconjugation Service by Region (2021-2026)
8.2 Middle East & Africa Oligonucleotide Bioconjugation Service Market Size by Type (2021-2026)
8.3 Middle East & Africa Oligonucleotide Bioconjugation Service Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL OLIGONUCLEOTIDE BIOCONJUGATION SERVICE MARKET FORECAST

10.1 Global Oligonucleotide Bioconjugation Service Forecast by Region (2027-2032)
  10.1.1 Global Oligonucleotide Bioconjugation Service Forecast by Region (2027-2032)
  10.1.2 Americas Oligonucleotide Bioconjugation Service Forecast
  10.1.3 APAC Oligonucleotide Bioconjugation Service Forecast
  10.1.4 Europe Oligonucleotide Bioconjugation Service Forecast
  10.1.5 Middle East & Africa Oligonucleotide Bioconjugation Service Forecast
10.2 Americas Oligonucleotide Bioconjugation Service Forecast by Country (2027-2032)
  10.2.1 United States Market Oligonucleotide Bioconjugation Service Forecast
  10.2.2 Canada Market Oligonucleotide Bioconjugation Service Forecast
  10.2.3 Mexico Market Oligonucleotide Bioconjugation Service Forecast
  10.2.4 Brazil Market Oligonucleotide Bioconjugation Service Forecast
10.3 APAC Oligonucleotide Bioconjugation Service Forecast by Region (2027-2032)
  10.3.1 China Oligonucleotide Bioconjugation Service Market Forecast
  10.3.2 Japan Market Oligonucleotide Bioconjugation Service Forecast
  10.3.3 Korea Market Oligonucleotide Bioconjugation Service Forecast
  10.3.4 Southeast Asia Market Oligonucleotide Bioconjugation Service Forecast
  10.3.5 India Market Oligonucleotide Bioconjugation Service Forecast
  10.3.6 Australia Market Oligonucleotide Bioconjugation Service Forecast
10.4 Europe Oligonucleotide Bioconjugation Service Forecast by Country (2027-2032)
  10.4.1 Germany Market Oligonucleotide Bioconjugation Service Forecast
  10.4.2 France Market Oligonucleotide Bioconjugation Service Forecast
  10.4.3 UK Market Oligonucleotide Bioconjugation Service Forecast
  10.4.4 Italy Market Oligonucleotide Bioconjugation Service Forecast
  10.4.5 Russia Market Oligonucleotide Bioconjugation Service Forecast
10.5 Middle East & Africa Oligonucleotide Bioconjugation Service Forecast by Region (2027-2032)
  10.5.1 Egypt Market Oligonucleotide Bioconjugation Service Forecast
  10.5.2 South Africa Market Oligonucleotide Bioconjugation Service Forecast
  10.5.3 Israel Market Oligonucleotide Bioconjugation Service Forecast
  10.5.4 Turkey Market Oligonucleotide Bioconjugation Service Forecast
10.6 Global Oligonucleotide Bioconjugation Service Forecast by Type (2027-2032)
10.7 Global Oligonucleotide Bioconjugation Service Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Oligonucleotide Bioconjugation Service Forecast

11 KEY PLAYERS ANALYSIS

11.1 WuXi TIDES
  11.1.1 WuXi TIDES Company Information
  11.1.2 WuXi TIDES Oligonucleotide Bioconjugation Service Product Offered
  11.1.3 WuXi TIDES Oligonucleotide Bioconjugation Service Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 WuXi TIDES Main Business Overview
  11.1.5 WuXi TIDES Latest Developments
11.2 Bio-Synthesis Inc
  11.2.1 Bio-Synthesis Inc Company Information
  11.2.2 Bio-Synthesis Inc Oligonucleotide Bioconjugation Service Product Offered
  11.2.3 Bio-Synthesis Inc Oligonucleotide Bioconjugation Service Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 Bio-Synthesis Inc Main Business Overview
  11.2.5 Bio-Synthesis Inc Latest Developments
11.3 Creative Biolabs
  11.3.1 Creative Biolabs Company Information
  11.3.2 Creative Biolabs Oligonucleotide Bioconjugation Service Product Offered
  11.3.3 Creative Biolabs Oligonucleotide Bioconjugation Service Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 Creative Biolabs Main Business Overview
  11.3.5 Creative Biolabs Latest Developments
11.4 Creative Biogene (IntegrateRNA)
  11.4.1 Creative Biogene (IntegrateRNA) Company Information
  11.4.2 Creative Biogene (IntegrateRNA) Oligonucleotide Bioconjugation Service Product Offered
  11.4.3 Creative Biogene (IntegrateRNA) Oligonucleotide Bioconjugation Service Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 Creative Biogene (IntegrateRNA) Main Business Overview
  11.4.5 Creative Biogene (IntegrateRNA) Latest Developments
11.5 CPC Scientific Inc.
  11.5.1 CPC Scientific Inc. Company Information
  11.5.2 CPC Scientific Inc. Oligonucleotide Bioconjugation Service Product Offered
  11.5.3 CPC Scientific Inc. Oligonucleotide Bioconjugation Service Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 CPC Scientific Inc. Main Business Overview
  11.5.5 CPC Scientific Inc. Latest Developments
11.6 BOCSCI Inc.
  11.6.1 BOCSCI Inc. Company Information
  11.6.2 BOCSCI Inc. Oligonucleotide Bioconjugation Service Product Offered
  11.6.3 BOCSCI Inc. Oligonucleotide Bioconjugation Service Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 BOCSCI Inc. Main Business Overview
  11.6.5 BOCSCI Inc. Latest Developments
11.7 LifeTein
  11.7.1 LifeTein Company Information
  11.7.2 LifeTein Oligonucleotide Bioconjugation Service Product Offered
  11.7.3 LifeTein Oligonucleotide Bioconjugation Service Revenue, Gross Margin and Market Share (2021-2026)
  11.7.4 LifeTein Main Business Overview
  11.7.5 LifeTein Latest Developments
11.8 Ajinomoto
  11.8.1 Ajinomoto Company Information
  11.8.2 Ajinomoto Oligonucleotide Bioconjugation Service Product Offered
  11.8.3 Ajinomoto Oligonucleotide Bioconjugation Service Revenue, Gross Margin and Market Share (2021-2026)
  11.8.4 Ajinomoto Main Business Overview
  11.8.5 Ajinomoto Latest Developments
11.9 SBS Genetech
  11.9.1 SBS Genetech Company Information
  11.9.2 SBS Genetech Oligonucleotide Bioconjugation Service Product Offered
  11.9.3 SBS Genetech Oligonucleotide Bioconjugation Service Revenue, Gross Margin and Market Share (2021-2026)
  11.9.4 SBS Genetech Main Business Overview
  11.9.5 SBS Genetech Latest Developments
11.10 Medtide Inc.
  11.10.1 Medtide Inc. Company Information
  11.10.2 Medtide Inc. Oligonucleotide Bioconjugation Service Product Offered
  11.10.3 Medtide Inc. Oligonucleotide Bioconjugation Service Revenue, Gross Margin and Market Share (2021-2026)
  11.10.4 Medtide Inc. Main Business Overview
  11.10.5 Medtide Inc. Latest Developments
11.11 Kaneka Corporation(Eurogentec)
  11.11.1 Kaneka Corporation(Eurogentec) Company Information
  11.11.2 Kaneka Corporation(Eurogentec) Oligonucleotide Bioconjugation Service Product Offered
  11.11.3 Kaneka Corporation(Eurogentec) Oligonucleotide Bioconjugation Service Revenue, Gross Margin and Market Share (2021-2026)
  11.11.4 Kaneka Corporation(Eurogentec) Main Business Overview
  11.11.5 Kaneka Corporation(Eurogentec) Latest Developments
11.12 Rockland
  11.12.1 Rockland Company Information
  11.12.2 Rockland Oligonucleotide Bioconjugation Service Product Offered
  11.12.3 Rockland Oligonucleotide Bioconjugation Service Revenue, Gross Margin and Market Share (2021-2026)
  11.12.4 Rockland Main Business Overview
  11.12.5 Rockland Latest Developments
11.13 CellMosaic
  11.13.1 CellMosaic Company Information
  11.13.2 CellMosaic Oligonucleotide Bioconjugation Service Product Offered
  11.13.3 CellMosaic Oligonucleotide Bioconjugation Service Revenue, Gross Margin and Market Share (2021-2026)
  11.13.4 CellMosaic Main Business Overview
  11.13.5 CellMosaic Latest Developments
11.14 Leinco
  11.14.1 Leinco Company Information
  11.14.2 Leinco Oligonucleotide Bioconjugation Service Product Offered
  11.14.3 Leinco Oligonucleotide Bioconjugation Service Revenue, Gross Margin and Market Share (2021-2026)
  11.14.4 Leinco Main Business Overview
  11.14.5 Leinco Latest Developments
11.15 Lonza
  11.15.1 Lonza Company Information
  11.15.2 Lonza Oligonucleotide Bioconjugation Service Product Offered
  11.15.3 Lonza Oligonucleotide Bioconjugation Service Revenue, Gross Margin and Market Share (2021-2026)
  11.15.4 Lonza Main Business Overview
  11.15.5 Lonza Latest Developments
11.16 ChemExpress
  11.16.1 ChemExpress Company Information
  11.16.2 ChemExpress Oligonucleotide Bioconjugation Service Product Offered
  11.16.3 ChemExpress Oligonucleotide Bioconjugation Service Revenue, Gross Margin and Market Share (2021-2026)
  11.16.4 ChemExpress Main Business Overview
  11.16.5 ChemExpress Latest Developments
11.17 GTP Bioways
  11.17.1 GTP Bioways Company Information
  11.17.2 GTP Bioways Oligonucleotide Bioconjugation Service Product Offered
  11.17.3 GTP Bioways Oligonucleotide Bioconjugation Service Revenue, Gross Margin and Market Share (2021-2026)
  11.17.4 GTP Bioways Main Business Overview
  11.17.5 GTP Bioways Latest Developments
11.18 Biosynth
  11.18.1 Biosynth Company Information
  11.18.2 Biosynth Oligonucleotide Bioconjugation Service Product Offered
  11.18.3 Biosynth Oligonucleotide Bioconjugation Service Revenue, Gross Margin and Market Share (2021-2026)
  11.18.4 Biosynth Main Business Overview
  11.18.5 Biosynth Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

LIST OF TABLES

Table 1. Oligonucleotide Bioconjugation Service Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Oligonucleotide Bioconjugation Service Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Oligonucleotide-Peptide
Table 4. Major Players of Oligonucleotide-Antibody
Table 5. Major Players of Oligonucleotide-Lipid
Table 6. Major Players of Oligonucleotide-Toxin
Table 7. Major Players of Oligonucleotide-GalNAc
Table 8. Major Players of Other
Table 9. Oligonucleotide Bioconjugation Service Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Oligonucleotide Bioconjugation Service Market Size by Type (2021-2026) & ($ millions)
Table 11. Global Oligonucleotide Bioconjugation Service Market Size Market Share by Type (2021-2026)
Table 12. Oligonucleotide Bioconjugation Service Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 13. Global Oligonucleotide Bioconjugation Service Market Size by Application (2021-2026) & ($ millions)
Table 14. Global Oligonucleotide Bioconjugation Service Market Size Market Share by Application (2021-2026)
Table 15. Global Oligonucleotide Bioconjugation Service Revenue by Player (2021-2026) & ($ millions)
Table 16. Global Oligonucleotide Bioconjugation Service Revenue Market Share by Player (2021-2026)
Table 17. Oligonucleotide Bioconjugation Service Key Players Head office and Products Offered
Table 18. Oligonucleotide Bioconjugation Service Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Oligonucleotide Bioconjugation Service Market Size by Region (2021-2026) & ($ millions)
Table 22. Global Oligonucleotide Bioconjugation Service Market Size Market Share by Region (2021-2026)
Table 23. Global Oligonucleotide Bioconjugation Service Revenue by Country/Region (2021-2026) & ($ millions)
Table 24. Global Oligonucleotide Bioconjugation Service Revenue Market Share by Country/Region (2021-2026)
Table 25. Americas Oligonucleotide Bioconjugation Service Market Size by Country (2021-2026) & ($ millions)
Table 26. Americas Oligonucleotide Bioconjugation Service Market Size Market Share by Country (2021-2026)
Table 27. Americas Oligonucleotide Bioconjugation Service Market Size by Type (2021-2026) & ($ millions)
Table 28. Americas Oligonucleotide Bioconjugation Service Market Size Market Share by Type (2021-2026)
Table 29. Americas Oligonucleotide Bioconjugation Service Market Size by Application (2021-2026) & ($ millions)
Table 30. Americas Oligonucleotide Bioconjugation Service Market Size Market Share by Application (2021-2026)
Table 31. APAC Oligonucleotide Bioconjugation Service Market Size by Region (2021-2026) & ($ millions)
Table 32. APAC Oligonucleotide Bioconjugation Service Market Size Market Share by Region (2021-2026)
Table 33. APAC Oligonucleotide Bioconjugation Service Market Size by Type (2021-2026) & ($ millions)
Table 34. APAC Oligonucleotide Bioconjugation Service Market Size by Application (2021-2026) & ($ millions)
Table 35. Europe Oligonucleotide Bioconjugation Service Market Size by Country (2021-2026) & ($ millions)
Table 36. Europe Oligonucleotide Bioconjugation Service Market Size Market Share by Country (2021-2026)
Table 37. Europe Oligonucleotide Bioconjugation Service Market Size by Type (2021-2026) & ($ millions)
Table 38. Europe Oligonucleotide Bioconjugation Service Market Size by Application (2021-2026) & ($ millions)
Table 39. Middle East & Africa Oligonucleotide Bioconjugation Service Market Size by Region (2021-2026) & ($ millions)
Table 40. Middle East & Africa Oligonucleotide Bioconjugation Service Market Size by Type (2021-2026) & ($ millions)
Table 41. Middle East & Africa Oligonucleotide Bioconjugation Service Market Size by Application (2021-2026) & ($ millions)
Table 42. Key Market Drivers & Growth Opportunities of Oligonucleotide Bioconjugation Service
Table 43. Key Market Challenges & Risks of Oligonucleotide Bioconjugation Service
Table 44. Key Industry Trends of Oligonucleotide Bioconjugation Service
Table 45. Global Oligonucleotide Bioconjugation Service Market Size Forecast by Region (2027-2032) & ($ millions)
Table 46. Global Oligonucleotide Bioconjugation Service Market Size Market Share Forecast by Region (2027-2032)
Table 47. Global Oligonucleotide Bioconjugation Service Market Size Forecast by Type (2027-2032) & ($ millions)
Table 48. Global Oligonucleotide Bioconjugation Service Market Size Forecast by Application (2027-2032) & ($ millions)
Table 49. WuXi TIDES Details, Company Type, Oligonucleotide Bioconjugation Service Area Served and Its Competitors
Table 50. WuXi TIDES Oligonucleotide Bioconjugation Service Product Offered
Table 51. WuXi TIDES Oligonucleotide Bioconjugation Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 52. WuXi TIDES Main Business
Table 53. WuXi TIDES Latest Developments
Table 54. Bio-Synthesis Inc Details, Company Type, Oligonucleotide Bioconjugation Service Area Served and Its Competitors
Table 55. Bio-Synthesis Inc Oligonucleotide Bioconjugation Service Product Offered
Table 56. Bio-Synthesis Inc Oligonucleotide Bioconjugation Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 57. Bio-Synthesis Inc Main Business
Table 58. Bio-Synthesis Inc Latest Developments
Table 59. Creative Biolabs Details, Company Type, Oligonucleotide Bioconjugation Service Area Served and Its Competitors
Table 60. Creative Biolabs Oligonucleotide Bioconjugation Service Product Offered
Table 61. Creative Biolabs Oligonucleotide Bioconjugation Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 62. Creative Biolabs Main Business
Table 63. Creative Biolabs Latest Developments
Table 64. Creative Biogene (IntegrateRNA) Details, Company Type, Oligonucleotide Bioconjugation Service Area Served and Its Competitors
Table 65. Creative Biogene (IntegrateRNA) Oligonucleotide Bioconjugation Service Product Offered
Table 66. Creative Biogene (IntegrateRNA) Oligonucleotide Bioconjugation Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 67. Creative Biogene (IntegrateRNA) Main Business
Table 68. Creative Biogene (IntegrateRNA) Latest Developments
Table 69. CPC Scientific Inc. Details, Company Type, Oligonucleotide Bioconjugation Service Area Served and Its Competitors
Table 70. CPC Scientific Inc. Oligonucleotide Bioconjugation Service Product Offered
Table 71. CPC Scientific Inc. Oligonucleotide Bioconjugation Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 72. CPC Scientific Inc. Main Business
Table 73. CPC Scientific Inc. Latest Developments
Table 74. BOCSCI Inc. Details, Company Type, Oligonucleotide Bioconjugation Service Area Served and Its Competitors
Table 75. BOCSCI Inc. Oligonucleotide Bioconjugation Service Product Offered
Table 76. BOCSCI Inc. Oligonucleotide Bioconjugation Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 77. BOCSCI Inc. Main Business
Table 78. BOCSCI Inc. Latest Developments
Table 79. LifeTein Details, Company Type, Oligonucleotide Bioconjugation Service Area Served and Its Competitors
Table 80. LifeTein Oligonucleotide Bioconjugation Service Product Offered
Table 81. LifeTein Oligonucleotide Bioconjugation Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 82. LifeTein Main Business
Table 83. LifeTein Latest Developments
Table 84. Ajinomoto Details, Company Type, Oligonucleotide Bioconjugation Service Area Served and Its Competitors
Table 85. Ajinomoto Oligonucleotide Bioconjugation Service Product Offered
Table 86. Ajinomoto Oligonucleotide Bioconjugation Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 87. Ajinomoto Main Business
Table 88. Ajinomoto Latest Developments
Table 89. SBS Genetech Details, Company Type, Oligonucleotide Bioconjugation Service Area Served and Its Competitors
Table 90. SBS Genetech Oligonucleotide Bioconjugation Service Product Offered
Table 91. SBS Genetech Oligonucleotide Bioconjugation Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 92. SBS Genetech Main Business
Table 93. SBS Genetech Latest Developments
Table 94. Medtide Inc. Details, Company Type, Oligonucleotide Bioconjugation Service Area Served and Its Competitors
Table 95. Medtide Inc. Oligonucleotide Bioconjugation Service Product Offered
Table 96. Medtide Inc. Oligonucleotide Bioconjugation Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 97. Medtide Inc. Main Business
Table 98. Medtide Inc. Latest Developments
Table 99. Kaneka Corporation(Eurogentec) Details, Company Type, Oligonucleotide Bioconjugation Service Area Served and Its Competitors
Table 100. Kaneka Corporation(Eurogentec) Oligonucleotide Bioconjugation Service Product Offered
Table 101. Kaneka Corporation(Eurogentec) Oligonucleotide Bioconjugation Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 102. Kaneka Corporation(Eurogentec) Main Business
Table 103. Kaneka Corporation(Eurogentec) Latest Developments
Table 104. Rockland Details, Company Type, Oligonucleotide Bioconjugation Service Area Served and Its Competitors
Table 105. Rockland Oligonucleotide Bioconjugation Service Product Offered
Table 106. Rockland Oligonucleotide Bioconjugation Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 107. Rockland Main Business
Table 108. Rockland Latest Developments
Table 109. CellMosaic Details, Company Type, Oligonucleotide Bioconjugation Service Area Served and Its Competitors
Table 110. CellMosaic Oligonucleotide Bioconjugation Service Product Offered
Table 111. CellMosaic Oligonucleotide Bioconjugation Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 112. CellMosaic Main Business
Table 113. CellMosaic Latest Developments
Table 114. Leinco Details, Company Type, Oligonucleotide Bioconjugation Service Area Served and Its Competitors
Table 115. Leinco Oligonucleotide Bioconjugation Service Product Offered
Table 116. Leinco Oligonucleotide Bioconjugation Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 117. Leinco Main Business
Table 118. Leinco Latest Developments
Table 119. Lonza Details, Company Type, Oligonucleotide Bioconjugation Service Area Served and Its Competitors
Table 120. Lonza Oligonucleotide Bioconjugation Service Product Offered
Table 121. Lonza Oligonucleotide Bioconjugation Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 122. Lonza Main Business
Table 123. Lonza Latest Developments
Table 124. ChemExpress Details, Company Type, Oligonucleotide Bioconjugation Service Area Served and Its Competitors
Table 125. ChemExpress Oligonucleotide Bioconjugation Service Product Offered
Table 126. ChemExpress Oligonucleotide Bioconjugation Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 127. ChemExpress Main Business
Table 128. ChemExpress Latest Developments
Table 129. GTP Bioways Details, Company Type, Oligonucleotide Bioconjugation Service Area Served and Its Competitors
Table 130. GTP Bioways Oligonucleotide Bioconjugation Service Product Offered
Table 131. GTP Bioways Oligonucleotide Bioconjugation Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 132. GTP Bioways Main Business
Table 133. GTP Bioways Latest Developments
Table 134. Biosynth Details, Company Type, Oligonucleotide Bioconjugation Service Area Served and Its Competitors
Table 135. Biosynth Oligonucleotide Bioconjugation Service Product Offered
Table 136. Biosynth Oligonucleotide Bioconjugation Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 137. Biosynth Main Business
Table 138. Biosynth Latest Developments

LIST OF FIGURES

Figure 1. Oligonucleotide Bioconjugation Service Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oligonucleotide Bioconjugation Service Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Oligonucleotide Bioconjugation Service Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Oligonucleotide Bioconjugation Service Sales Market Share by Country/Region (2025)
Figure 8. Oligonucleotide Bioconjugation Service Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Oligonucleotide Bioconjugation Service Market Size Market Share by Type in 2025
Figure 10. Oligonucleotide Bioconjugation Service in Scientific Research
Figure 11. Global Oligonucleotide Bioconjugation Service Market: Scientific Research (2021-2026) & ($ millions)
Figure 12. Oligonucleotide Bioconjugation Service in Pharmaceuticals
Figure 13. Global Oligonucleotide Bioconjugation Service Market: Pharmaceuticals (2021-2026) & ($ millions)
Figure 14. Global Oligonucleotide Bioconjugation Service Market Size Market Share by Application in 2025
Figure 15. Global Oligonucleotide Bioconjugation Service Revenue Market Share by Player in 2025
Figure 16. Global Oligonucleotide Bioconjugation Service Market Size Market Share by Region (2021-2026)
Figure 17. Americas Oligonucleotide Bioconjugation Service Market Size 2021-2026 ($ millions)
Figure 18. APAC Oligonucleotide Bioconjugation Service Market Size 2021-2026 ($ millions)
Figure 19. Europe Oligonucleotide Bioconjugation Service Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa Oligonucleotide Bioconjugation Service Market Size 2021-2026 ($ millions)
Figure 21. Americas Oligonucleotide Bioconjugation Service Value Market Share by Country in 2025
Figure 22. United States Oligonucleotide Bioconjugation Service Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada Oligonucleotide Bioconjugation Service Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico Oligonucleotide Bioconjugation Service Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil Oligonucleotide Bioconjugation Service Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC Oligonucleotide Bioconjugation Service Market Size Market Share by Region in 2025
Figure 27. APAC Oligonucleotide Bioconjugation Service Market Size Market Share by Type (2021-2026)
Figure 28. APAC Oligonucleotide Bioconjugation Service Market Size Market Share by Application (2021-2026)
Figure 29. China Oligonucleotide Bioconjugation Service Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan Oligonucleotide Bioconjugation Service Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea Oligonucleotide Bioconjugation Service Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia Oligonucleotide Bioconjugation Service Market Size Growth 2021-2026 ($ millions)
Figure 33. India Oligonucleotide Bioconjugation Service Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia Oligonucleotide Bioconjugation Service Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe Oligonucleotide Bioconjugation Service Market Size Market Share by Country in 2025
Figure 36. Europe Oligonucleotide Bioconjugation Service Market Size Market Share by Type (2021-2026)
Figure 37. Europe Oligonucleotide Bioconjugation Service Market Size Market Share by Application (2021-2026)
Figure 38. Germany Oligonucleotide Bioconjugation Service Market Size Growth 2021-2026 ($ millions)
Figure 39. France Oligonucleotide Bioconjugation Service Market Size Growth 2021-2026 ($ millions)
Figure 40. UK Oligonucleotide Bioconjugation Service Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy Oligonucleotide Bioconjugation Service Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia Oligonucleotide Bioconjugation Service Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa Oligonucleotide Bioconjugation Service Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa Oligonucleotide Bioconjugation Service Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa Oligonucleotide Bioconjugation Service Market Size Market Share by Application (2021-2026)
Figure 46. Egypt Oligonucleotide Bioconjugation Service Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa Oligonucleotide Bioconjugation Service Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel Oligonucleotide Bioconjugation Service Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey Oligonucleotide Bioconjugation Service Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries Oligonucleotide Bioconjugation Service Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas Oligonucleotide Bioconjugation Service Market Size 2027-2032 ($ millions)
Figure 52. APAC Oligonucleotide Bioconjugation Service Market Size 2027-2032 ($ millions)
Figure 53. Europe Oligonucleotide Bioconjugation Service Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa Oligonucleotide Bioconjugation Service Market Size 2027-2032 ($ millions)
Figure 55. United States Oligonucleotide Bioconjugation Service Market Size 2027-2032 ($ millions)
Figure 56. Canada Oligonucleotide Bioconjugation Service Market Size 2027-2032 ($ millions)
Figure 57. Mexico Oligonucleotide Bioconjugation Service Market Size 2027-2032 ($ millions)
Figure 58. Brazil Oligonucleotide Bioconjugation Service Market Size 2027-2032 ($ millions)
Figure 59. China Oligonucleotide Bioconjugation Service Market Size 2027-2032 ($ millions)
Figure 60. Japan Oligonucleotide Bioconjugation Service Market Size 2027-2032 ($ millions)
Figure 61. Korea Oligonucleotide Bioconjugation Service Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia Oligonucleotide Bioconjugation Service Market Size 2027-2032 ($ millions)
Figure 63. India Oligonucleotide Bioconjugation Service Market Size 2027-2032 ($ millions)
Figure 64. Australia Oligonucleotide Bioconjugation Service Market Size 2027-2032 ($ millions)
Figure 65. Germany Oligonucleotide Bioconjugation Service Market Size 2027-2032 ($ millions)
Figure 66. France Oligonucleotide Bioconjugation Service Market Size 2027-2032 ($ millions)
Figure 67. UK Oligonucleotide Bioconjugation Service Market Size 2027-2032 ($ millions)
Figure 68. Italy Oligonucleotide Bioconjugation Service Market Size 2027-2032 ($ millions)
Figure 69. Russia Oligonucleotide Bioconjugation Service Market Size 2027-2032 ($ millions)
Figure 70. Egypt Oligonucleotide Bioconjugation Service Market Size 2027-2032 ($ millions)
Figure 71. South Africa Oligonucleotide Bioconjugation Service Market Size 2027-2032 ($ millions)
Figure 72. Israel Oligonucleotide Bioconjugation Service Market Size 2027-2032 ($ millions)
Figure 73. Turkey Oligonucleotide Bioconjugation Service Market Size 2027-2032 ($ millions)
Figure 74. Global Oligonucleotide Bioconjugation Service Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global Oligonucleotide Bioconjugation Service Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries Oligonucleotide Bioconjugation Service Market Size 2027-2032 ($ millions)


More Publications